Global Reach Oncovision sells its imaging devices in over 30 markets through direct sales and distributors, indicating a broad addressable market and multi-channel sales opportunities for expansion, partnerships, and regionalized demos.

Clinical Pipeline With a diversified product line including Sentinella, MAMMI PET, Wprobe, and Albira, there are cross-selling opportunities across oncology imaging and radioguided procedures, plus potential upsell to bundled solutions for cancer diagnosis and surgery.

High-Impact Tech Advanced imaging technologies and intra-operative gamma cameras position Oncovision to target high-value hospitals and cancer centers seeking cutting-edge solutions, enabling value-based conversations around diagnostic accuracy and workflow efficiency.

Growth & Investment Recent funding of around $10M and a revenue profile under $1M suggest opportunities to present scalable business models, collaboration on cost-reduction via optimized manufacturing, and partnerships to accelerate market adoption.

Geographic Footprint Presence in Boston and Valencia with a multi-market footprint offers regional engagement strategies, local clinical references, and demonstrated capacity to support cross-border sales, service, and training.